These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Specific determinants of conantokins that dictate their selectivity for the NR2B subunit of N-methyl-D-aspartate receptors. Sheng Z, Prorok M, Castellino FJ. Neuroscience; 2010 Oct 27; 170(3):703-10. PubMed ID: 20688135 [Abstract] [Full Text] [Related]
6. NMDA receptor subunit-dependent modulation by conantokin-G and Ala7-conantokin-G. Ragnarsson L, Yasuda T, Lewis RJ, Dodd PR, Adams DJ. J Neurochem; 2006 Jan 27; 96(1):283-91. PubMed ID: 16336218 [Abstract] [Full Text] [Related]
7. Kinetic and mechanistic characterization of NMDA receptor antagonism by replacement and truncation variants of the conantokin peptides. Klein RC, Warder SE, Galdzicki Z, Castellino FJ, Prorok M. Neuropharmacology; 2001 Dec 27; 41(7):801-10. PubMed ID: 11684144 [Abstract] [Full Text] [Related]
13. NR2B-selective conantokin peptide inhibitors of the NMDA receptor display enhanced antinociceptive properties compared to non-selective conantokins. Xiao C, Huang Y, Dong M, Hu J, Hou S, Castellino FJ, Prorok M, Dai Q. Neuropeptides; 2008 Dec 27; 42(5-6):601-9. PubMed ID: 18992939 [Abstract] [Full Text] [Related]